Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-003497
Date:2019-01-09
Issuer: AMARIN CORP PLC\UK (AMRN)
Original Submission Date:

Reporting Person:

KALB MICHAEL WAYNE
C/O AMARIN PHARMA, INC.
1430 ROUTE 206 BEDMINSTER, NJ 07921

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2019-01-09 M 200,000 a $2.19 217,486 f4 direct
ORDINARY SHARES 2019-01-09 S 200,000 d $15.26 17,486 f4 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.19 2019-01-09 deemed execution date M 200,000 (d) 2026-07-01 ordinary shares 200,000 $2.19 275,000 direct
Footnotes
IDfootnote
f1 the option exercises and sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share.
f3 includes 1,006 shares purchased under the issuer's 2017 employee stock purchase plan (the "espp") on may 31, 2018, and 1,484 shares purchased under the espp on november 30, 2018.
f4 please see the section titled "remarks" below for additional information.
f5 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $15.25 to $15.30, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range.
f6 on july 1, 2016, the reporting person was granted an option to purchase 625,000 ordinary shares under the amarin corporation plc 2011 stock incentive plan (the "plan"). the shares subject to this option shall vest as follows: 25% of the total number of underlying shares shall vest on july 1, 2017, and the remaining 75% of the underlying shares shall vest ratably over the subsequent 36 months.
WhaleWisdom Logo

Elevate your investments